Expanded Access Program for Idebenone in Patients With Leber's Hereditary Optic Neuropathy Who Completed the LEROS Study

4D-150 in Patients With Diabetic Macular Edema

NCT05930561 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Phenotyping Diabetic Retinopathy

NCT00840541 ·Status: COMPLETED

Special Drug Use Investigation of EYLEA for Diabetic Macular Edema

NCT02425501 ·Status: COMPLETED

Safety and Efficacy of Aflibercept in Proliferative Diabetic Retinopathy.

NCT02151695 ·Status: COMPLETED ·Phase: PHASE2

Laser and Antioxidant Treatment of Diabetic Macular Edema

NCT00055042 ·Status: COMPLETED ·Phase: PHASE1

Study of EYP-1901 in Patients With Nonproliferative Diabetic Retinopathy (NPDR)

NCT05383209 ·Status: COMPLETED ·Phase: PHASE2

Comparison of Different Fluence Settings for Yellow Subthreshold Laser Treatment in Diabetic Macular Edema

NCT03571659 ·Status: COMPLETED

Effect of Levosulpiride on Retinal Alterations in Patients With Diabetic Retinopathy and Diabetic Macular Edema

NCT03161652 ·Status: RECRUITING ·Phase: PHASE2

The Fenofibrate And Microvascular Events in Type 1 Diabetes Eye.

NCT01320345 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Combination of Standard Lucentis Therapy With Micropulse Diode Laser for the Treatment of Diabetic Macular Edema

NCT02059772 ·Status: UNKNOWN ·Phase: PHASE4

Study of a High-Dose Aflibercept in Participants With Diabetic Eye Disease

NCT04429503 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

A Study to Learn More About the Use of Aflibercept in Routine Medical Practice in Japanese Participants With Neovascular Age-related Macular Degeneration and Diabetic Macular Edema

NCT06929143 ·Status: ACTIVE_NOT_RECRUITING

Longitudinal Natural History Study of Retinal Function in Eyes of Patients With Diabetes

NCT07270133 ·Status: NOT_YET_RECRUITING

Intravitreal Aflibercept Injection in Vision Impairment Due to DME

NCT01331681 ·Status: COMPLETED ·Phase: PHASE3

Routine Clinical Practice for Use of Intravitreal Aflibercept Treatment in Patients With Diabetic Macular Edema

NCT02924311 ·Status: COMPLETED

Effect of Intravenous Methylprednisolone and Intravenous Erythropoietin in Toxic Optic Neuropathies: Randomized Clinical Trial.

NCT05748561 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

Octreotide Acetate in Microspheres in Patients With Diabetic Retinopathy

NCT00130845 ·Status: COMPLETED ·Phase: PHASE3

Laser and Medical Treatment of Diabetic Macular Edema

NCT00050479 ·Status: COMPLETED ·Phase: PHASE3

Treatment of Optic Neuritis With Erythropoietin: a Randomised, Double-blind, Placebo-controlled Trial

NCT01962571 ·Status: COMPLETED ·Phase: PHASE3

Diabetic Retinopathy and Visual Function Study

NCT00001346 ·Status: COMPLETED

Study Evaluating Efficacy and Safety of PF-04523655 Versus Laser in Subjects With Diabetic Macular Edema

NCT00701181 ·Status: TERMINATED ·Phase: PHASE2

Fenofibrate for Prevention of DR Worsening

NCT04661358 ·Status: RECRUITING ·Phase: PHASE3

Long Term Follow-Up of Diabetic Retinopathy

NCT00001395 ·Status: COMPLETED

Assessment of EyeArt Performance With Retinal Imaging Devices

NCT04302012 ·Status: COMPLETED

Trial of Yellow 577 nm Laser Versus Green 532 nm Laser for Proliferative Diabetic Retinopathy

NCT01044875 ·Status: UNKNOWN ·Phase: NA